Biohaven Pharmaceutical Holding
New Haven, US · Founded 2013 · Incorporated in Virgin Islands, British
Founders & leadership
Biohaven Pharmaceutical Holding was founded in 2013 by Vladimir Coric, M.D..
VC
Vladimir Coric, M.D.CEO
JT
John TiltonExecutive
RB
Robert Berman, M.D.Executive
JE
Jim EngelhartExecutive
KG
Kimberly GentileExecutive
DD
Declan DooganNamed on SEC filing
Board
JC
John ChildsBoard director
GB
Greg BaileyBoard director
KS
Kam ShahBoard director
Reported raises · per SEC filings
Form D private placements$40M disclosed across 1 round · 2016
▶$40MraisedNov 2016 · 34 investors · PharmaceuticalsRule 506(b)
▶$40MraisedNov 2016 · 34 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John TiltonExecutive Officer
- Robert Berman, M.D.Executive Officer
- Jim EngelhartExecutive Officer
- Declan DooganDirector
- Vladimir Coric, M.D.Executive Officer, Director
- Kimberly GentileExecutive Officer
- John ChildsDirector
- Greg BaileyDirector
- Kam ShahDirector
- Offering amount
- $80M
- Amount sold
- $40M
- Sales commissions
- $4.6M
- Placement agents
- William Blair, Cowen and Company
- First sale
- Oct 2016
- Incorporated
- Other, Virgin Islands, British, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Biohaven Pharmaceutical Holding?
- Biohaven Pharmaceutical Holding was founded by Vladimir Coric, M.D. in 2013.
- How much funding has Biohaven Pharmaceutical Holding raised?
- Biohaven Pharmaceutical Holding has disclosed $40M raised across 1 round.
- Where is Biohaven Pharmaceutical Holding headquartered?
- Biohaven Pharmaceutical Holding is headquartered in New Haven, US.